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Objective: Thisstudywasconductedtodeterminewhethernitricoxide(NO),apotentvasodilatorandinhibitorof
thrombus formation, is involved in the formation and maintenance of adhesions.
Methods: Skin, subcutaneous tissues, peritoneum and adhesions were collected from surgical patients and total
RNA was isolated. Quantitative reverse transcription polymerase chain reaction (QRT-PCR) was performed to
quantitate endothelial nitric oxide synthase (eNOS) and b-actin mRNA levels.
Results: eNOS mRNA levels for skin, subcutaneous tissue, peritoneum and adhesions were £ 3.12 ´ 10
4,
£ 3.12 ´ 10
4, 6.24 ´ 10
4 and 2.5 ´ 10
3 attomoles/ml, respectively. b-actin mRNA levels for all tissues were
between 1.25 ´ 10
1 and 6.25 ´ 10
2 attomoles/ml.
Conclusion: eNOS mRNA can be identified in tissue adhesions, and may therefore play a role in adhesion forma-
tion and maintenance.
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Adhesions can result from surgically induced
trauma to the peritoneum or through inflamma-
tory and infection processes arising from such
conditions as endometriosis, pelvic inflammatory
disease (PID) and appendicitis. Intraperitoneal
adhesions within the pelvis often result in inferti-
lity, recurrent pelvic pain,small bowelobstruction
and fixation as well as difficult re-operative
surgery. These factors contribute substantially to
patient morbidity and result in a dramatic escala-
tion in health care costs1,2. Consequently, there is
a pressing medical need to more fully define
the pathophysiology underlying adhesion
development.
The stimuli responsible for initiating adhesion
formation are incompletely understood. How-
ever, ischemia and hypoxia are recognized as
important initiating events. Likewise, the
infection-mediated cascade of inflammatory by-
products may play a role in adhesion formation.
Vascular infiltration within fibrinous adhesive
bands has also been recognized as an important
step in the formation of some adhesions3. The
mediators necessary for the development and
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Clinical study 113maintenance of perfusion within adhesions are at
present unknown.However, a probablecandidate
responsible for maintaining vascular homeostasis,
preventing thrombus formation and inhibiting
vasoconstriction is nitric oxide (NO).
NO is a potent and labile vasodilator that is
produced by three genetically distinct isoforms
of nitric oxide synthase including neuronal
(nNOS), inducible (iNOS) and constitutive NOS
(cNOS)4–6. Endothelial nitric oxide synthase
(eNOS), a constitutive form of NOS, plays a vital
role in the regulation and maintenance of vascular
smooth muscle tone. eNOS also inhibits platelet
aggregation and attenuates the action of certain
vasoconstrictors7. eNOS transcription is known
to be regulated by hormones, shear stress, pro-
inflammatory cytokines and hypoxia8–11. Wound
healing, a process analogous in many respects to
adhesion formation, has been associated with
increased NO levels12,13.
This pilot study was conducted to determine
whether transcriptional expression of eNOS could
be identified in intraperitoneal adhesion tissues.
Specifically, the presence and level of eNOS
mRNA transcripts were determined within adhe-
sions and analyzed for comparison in skin, sub-
cutaneous tissue and normal peritoneum by
quantitativereverse transcriptionpolymerasechain
reaction (QRT-PCR).
METHODS
Sample collection and RNA isolation
Skin, subcutaneous tissue, peritoneum and intra-
abdominal adhesions (n = 3 per tissue type) were
obtained from surgical patients undergoing gyne-
cologic procedures and stored at 70°C. No
attempts were made toclinically establish thecause
or longevity of the adhesions. Tissue samples were
pulverized under liquid nitrogen. Total RNA was
isolated using the TrizolÒ reagent (GIBCO BRL,
Gaithersburg,MD), in accordancewith themanu-
facturer’s instructions. RNA was rendered free of
contaminating genomic DNA by treatment with
RQ1 DNase (5 U/100 mg of tissue), for 90 min at
room temperature (Promega, Madison, WI).
RNA integrity was confirmed by gel electro-
phoresis and quantitated spectrophotometrically at
260 nm and 280 nm. RNA was subsequently
storedat 70°C inthepresence oftheribonuclease
inhibitor RNasin (40 U/sample) (Promega,
Madison, WI). All specimens were collected with
prior approval and in accordance with guidelines
established by the Wayne State University,
University of Florida and the University of
Goteborg Institutional Review Boards.
Quantitativereverse transcriptionpolymerase
chain reaction
QRT-PCR is a highly sensitive technique that
enables the amplification and quantitation of
specific cDNA transcripts. A non-homologous
DNA fragment of knownconcentrationand bear-
ing the same eNOS or b-actin primer sites served
as the competitive internal standard or MIMIC.
Equimolar concentrationsof thecDNA of interest
andMIMICwillyield PCRproductswith equiva-
lentbandintensities, therebyenablingquantitation
and comparison among groups. b-actin mRNA
concentrations, as determined by QRT-PCR,
were used to control for minor differences in the
concentration of total RNA used in all reactions.
Total RNA (1 mg) was reverse transcribed at
70°C for1 hin a50 ml reactionvolume containing
rTth DNA polymerase (5 U), dNTPs (150 mM),
Mn(OAc)2 (2.0 mM), b-actin or eNOS anti-sense
and sense primers (2.5 mM), b-actin MIMICs
(5 ´ 10 1 to 6.25 ´ 10 2 attomoles) or eNOS
MIMICs (5 ´ 10 3 to 3.12 ´ 10 4 attomoles), and
1X EZ Buffer (Perkin Elmer Corp., Applied Bio-
systems Division, Foster City, CA). The resultant
cDNA was denatured at 95°C for 2 min and used
directly for QRT-PCR. DNA was denatured at
95°C for45 s,annealedat 72°C for45 sandampli-
fied at 60°C for 45 s, for 35 cycles. Amplification
was concluded with a single terminal extension
period at 72°C for 15 min. Cycle number and
cDNA concentrationwere adjusted so that ampli-
fied products remained within the linear range of
the PCR reaction. PCR amplification was con-
ducted on a Perkin Elmer DNA Thermal Cycler
480 (Perkin Elmer Corp., Norwalk, CT).
Human-specific b-actin and eNOS amplimers and
MIMICs were synthesized commercially using
sequence data available in the public domain
(Integrated DNA technologies, Inc., Coralville,
IA).Amplimersusedin thisstudywere designed to
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contaminating genomic DNA. PCR products
were resolved electrophoretically and size was
confirmed by comparison with a molecular size
standard (l DNA, Pvu II digest). Band intensities
were determined by scanning laser densitometry.
RESULTS
QRT-PCR amplification of skin, subcutaneous
tissue, peritoneum and adhesions yielded antici-
pated products of 309 bp and 537 bp for the
b-actin cDNA and MIMIC and 551 bp and
441 bp for the eNOS cDNA and MIMIC, respec-
tively. b-actinmRNA concentrationsforalltissues
were between 1.25 ´ 10 1 and 6.25 ´ 10 2
attomoles/ml (Figure 1). Representative eNOS
mRNA concentrations for skin, subcutaneous tis-
sue,peritoneumandadhesionswere£ 3.12 ´ 10 4,
£ 3.12 ´ 10 4, 6.24 ´ 10 4 and 2.5 ´ 10 3
attomoles/ml, respectively (Figure 2). Similar
levels of mRNA transcription were seen in all
tissue samples studied. The level of eNOS mRNA
found in adhesions was approximately 4-fold
greater than that found in intact peritoneal tissue
and approximately 8-fold greater than eNOS
mRNA levels foundineither skinorsubcutaneous
tissue.
DISCUSSION
The development of intraperitoneal adhesions
following infection, pelvic surgery or de novo are
prevalent gynecologic occurrences. Collectively,
intraperitoneal adhesions are a significant cause of
recurrent pelvic pain, small bowel fixation and
obstruction, difficult re-operative surgery and
infertility. Numerous adjuvants including fibrino-
lytic agents, anticoagulants, anti-inflammatory
agents, antibiotics and both chemical and physical
barriers have, with a limited effect, been used in an
effort to preclude the development of adhesions3.
For the most part these approaches have been
empirically derived. Better understanding of the
pathophysiology underlying adhesion formation,
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Figure 1 Quantitation of b-actin mRNA in skin, sub-
cutaneous tissue, peritoneum and adhesions by quantita-
tive reverse transcription polymerase chain reaction
(QRT-PCR). b-actin mRNA from skin, subcutaneous
tissue, peritoneum and adhesions was quantitated by
co-amplification with internal standards (MIMICs) of
known concentration (6.25 ´ 10
2 to 5 ´ 10
1
attomoles/ml). Amplification yielded anticipated b-actin
cDNA products of 309 base pairs (bp) and b-actin
MIMIC products of 537 bp. PCR product bands of equiv-
alent intensity are indicated by a box, for each tissue
type. The corresponding concentration of mRNA, in
attomoles/ml, is shown below
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Figure 2 Quantitation of endothelial nitric oxide
synthase (eNOS) mRNA in representative skin, subcuta-
neous tissue, peritoneum and adhesions by quantitative
reverse transcription polymerase chain reaction
(QRT-PCR). eNOS mRNA from skin, subcutaneous tis-
sue, peritoneum and adhesions was quantitated by
co-amplification with internal standards (MIMICs) of
known concentration (3.12 ´ 10
4 to 5 ´ 10
3
attomoles/ml). Amplification yielded predicted eNOS
cDNA products of 551 base pairs (bp) and eNOS MIMIC
products of 441 bp. PCR product bands of equivalent
intensity are indicated by a box for each tissue type
except in instances where mRNA concentrations are
below the lowest MIMIC concentration used. The
corresponding concentration of mRNA, in attomoles/ml,
is shown belowand how this may differ based on the inciting etio-
logy, is necessary for the development of effica-
cious interventions. Vascular support of formed
adhesionsviaeNOSorotherregulatorsisanareaof
research that deserves attention.
The data presented in this pilot study demon-
strate that adhesions transcriptionally express
eNOS. Furthermore, eNOS mRNA levels are
substantially greater in adhesions than in either
skin, subcutaneous tissue or normal peritoneum.
ThissuggeststhatNO may bean importantmodu-
lator of adhesion formation and maintenance.
These observations are supported by studies on
general wound healing, a process that is analogous
in many respects to the formation of adhesions.
NO expression is increased during woundhealing
and is necessary for both wound closure and the
maintenance of sufficient tensile strength11–14.
Work is currently underway to examine eNOS
expressioninadhesionsformedviadifferentpatho-
physiologic events (e.g. after PID, surgery, endo-
metriosis), and from various anatomic sites within
the pelvis. Timed studies examining the evolution
of adhesions (and their modulators) are also
needed. These types of investigation, focused on
eNOS expression, may reveal new targeted thera-
peutic modalities aimed at the regulation of perfu-
sion or vasculogenesis at sites of tissue injury.
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